Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Income Statement [Abstract] | ||||
| Sales | $ 74,027 | $ 0 | $ 74,027 | $ 0 |
| Cost of Sales | (72,357) | 0 | (72,357) | 0 |
| Gross Profit | 1,670 | 0 | 1,670 | 0 |
| Operating expenses: | ||||
| Research and development | 257,061 | 286,886 | 587,116 | 575,370 |
| General and administrative | 2,319,972 | 1,427,916 | 4,200,910 | 2,760,102 |
| Total operating expenses | 2,577,033 | 1,714,802 | 4,788,026 | 3,335,472 |
| Loss from operations | (2,575,363) | (1,714,802) | (4,786,356) | (3,335,472) |
| Interest expense | (1,503,114) | (1,779,462) | (3,271,418) | (3,502,517) |
| Net loss | (4,078,477) | (3,494,264) | (8,057,774) | (6,837,989) |
| Other comprehensive loss: | ||||
| Foreign currency translation adjustment | (957,471) | (107,151) | (1,420,408) | (117,857) |
| Comprehensive loss | $ (5,053,948) | $ (3,601,415) | $ (9,478,182) | $ (6,955,846) |
| Net loss per share, basic and diluted | $ (0.17) | $ (0.15) | $ (0.33) | $ (0.29) |
| Weighted average number of shares outstanding, basic and diluted | 24,102,866 | 23,308,049 | 24,102,866 | 23,209,514 |